ORYZON to present further positive efficacy data from iadademstat ALICE Phase IIa trial at the 62nd Congress of the American Society of Hematology Read more about ORYZON to present further positive efficacy data from iadademstat ALICE Phase IIa trial at the 62nd Congress of the American Society of Hematology
ORYZON receives approval to start PORTICO Phase IIb trial with vafidemstat in Borderline Personality Disorder Read more about ORYZON receives approval to start PORTICO Phase IIb trial with vafidemstat in Borderline Personality Disorder
Oryzon announces appointment of Dr. Torsten Hoffmann as Global R&D Director and retirement of Dr. Tamara Maes Read more about Oryzon announces appointment of Dr. Torsten Hoffmann as Global R&D Director and retirement of Dr. Tamara Maes
BHV Partners settles in the Barcelona Science Park and closes a 500,000 euros investment round Read more about BHV Partners settles in the Barcelona Science Park and closes a 500,000 euros investment round
Oryzon Reports Results for Quarter Ended September 30 Read more about Oryzon Reports Results for Quarter Ended September 30
Asphalion joins Barcelona Health Hub to boost technological and digital innovation in the healthcare sector Read more about Asphalion joins Barcelona Health Hub to boost technological and digital innovation in the healthcare sector
SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer Read more about SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer
ORYZON holds its 4th annual Solidarity Day Read more about ORYZON holds its 4th annual Solidarity Day
SOM Biotech announces poster presentation on the repurposing of Eravacycline for the treatment of SARS-CoV-2 Read more about SOM Biotech announces poster presentation on the repurposing of Eravacycline for the treatment of SARS-CoV-2
ORYZON publishes paper in Journal of Clinical Oncology demonstrating relevance of iadademstat in leukemia Read more about ORYZON publishes paper in Journal of Clinical Oncology demonstrating relevance of iadademstat in leukemia
